Molecular targeting of Gα and Gβγ subunits: a potential approach for cancer therapeutics

Area of Science:

• Pharmacology
• Molecular Biology
• Oncology

Background:

• G-Protein-coupled receptors (GPCRs) are crucial in physiological processes and are major drug targets.
• GPCR signaling involves G protein alpha (Gα) and beta-gamma (Gβγ) subunits.
• Targeting downstream effectors, including G proteins, is a promising therapeutic strategy for complex diseases.

Purpose of the Study:

• To discuss the requirements for targeting Gα and Gβγ subunits.
• To review the mechanisms of action of identified G protein inhibitors.
• To focus on the potential utility of Gα and Gβγ inhibitors in cancer treatment.

Main Methods:

• Review of existing literature on G protein subunit modulators.
• Analysis of small molecule inhibitors targeting Gα and Gβγ subunits.
• Evaluation of preclinical data from animal models of disease.

Main Results:

• Several small molecule modulators of Gα and Gβγ subunits have been developed.
• These modulators have shown potential in various animal models.
• The review synthesizes current knowledge on inhibitor mechanisms and therapeutic applications.

Conclusions:

• Targeting G protein subunits presents a viable therapeutic avenue.
• Gα and Gβγ inhibitors hold significant promise for the treatment of various cancers.
• Further research into G protein-targeted therapies is warranted.